ストックスクリーナーアプリを入手
200.29
0.85%
1.69
Resmed Inc (RMD) 最新ニュース
AirSense 10 ClimateLineAir Heated Tube from ResMed Inc.quieter nights with smarter humidity - Ad-hoc-news.de
ResMed muted ahead of next earnings, shares trade steadily on NYSE - Ad-hoc-news.de
OLD National Bancorp IN Has $4.58 Million Position in ResMed Inc. $RMD - MarketBeat
ResMed Inc. sees fresh institutional buying, shares hover near 200 dollars - Ad-hoc-news.de
ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh - TradingView
Price to earnings forward of ResMed Inc. – NYSE:RMD - TradingView
Price to earnings forward of ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh – MUN:RMEA - TradingView
Price to sales forward of ResMed Inc. – NYSE:RMD - TradingView
ResMed clears key trading range, shares hold firm between support and resistance - Ad-hoc-news.de
Should you continue to hold Resmed stock in your portfolio? - MSN
ResMed Inc. stock rises Thursday, outperforms market - MarketWatch
ResMed clears a fresh 52-week high, shares extend their Nasdaq run - Ad-hoc-news.de
Why ResMed Inc (RMD) Is Set to Outperform the Market: Insights i - GuruFocus
Price to book forward of ResMed Inc. – NYSE:RMD - TradingView
ResMed Stock is Down 20% in 2026. Is It a Buying Opportunity or a Warning Sign? - TIKR.com
ResMed Inc. Actuals & Estimates (NYSE:RMD) - TradingView
ResMed (ASX:RMD) Stock Moves Higher — What Investors Should Know? - Kalkine
Is ResMed Inc. (RMD) Stock Still a Long-Term Winner as OSA Market Expansion Continues? - Insider Monkey
Enterprise value to EBITDA forward of ResMed Inc. – NYSE:RMD - TradingView
ResMed opens the week with clear technical signals, shares trade in a defined range - Ad-hoc-news.de
Resmed Inc (RMD) Institutional Confidence - TradingKey
Did Morgan Stanley’s GLP-1 Downgrade Just Shift ResMed's (RMD) Investment Narrative? - Sahm
Resmed Inc (RMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Resmed Inc (RMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Should I buy CSL and ResMed shares right now? - The Motley Fool Australia
ResMed downgraded at Morgan Stanley on Philips re-entry and GLP-1 headwinds - MSN
ResMed edges higher after mixed analyst signals, shares trade near recent targets - AD HOC NEWS
Could ResMed (NYSE:RMD) Be Entering a New Chapter in Sleep Care? - Kalkine Media
ResMed trims KeyBanc price target, analyst views on the shares stay constructive - AD HOC NEWS
William Blair Maintains ResMed(RMD.US) With Buy Rating - Moomoo
KeyBanc Adjusts Price Target on ResMed to $266 From $290, Maintains Overweight Rating - marketscreener.com
ResMed Inc. (RMD) Stock Analysis: Unveiling A 39% Potential Upside Amidst Solid Growth - DirectorsTalk Interviews
Resmed Inc (RMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
KeyBanc Maintains ResMed(RMD.US) With Buy Rating, Announces Target Price $266 - Moomoo
Is ResMed (NYSE:RMD) Market Reset Creating New Interest? - Kalkine Media
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) was downgraded to a Hold Rating at Morgan Stanley - The Globe and Mail
Resmed Inc (RMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Is ResMed stock underperforming the Dow? - MSN
Stocks making big moves yesterday: Nubank, Ocular Therapeutix, Mondelez, ResMed, and Sonos - The Globe and Mail
Resmed Inc (RMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Resmed Inc (RMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ResMed Is Near Its 52-Week Low Despite 21% EPS Growth: What the GLP-1 Fear Is Getting Wrong - TIKR.com
ResMed Loses Bull as Margin Outlook Moderates -- Market Talk - Moomoo
Resmed Closes Acquisition of Noctrix Health - Moomoo
ResMed Inc (RMD) Stock Down 3.9% -- Now Undervalued? GF Score: 9 - GuruFocus
ResMed Inc. stock falls Wednesday, underperforms market - MarketWatch
Why ResMed (RMD) Shares Are Falling Today - Yahoo Finance
ResMed (RMD) Faces Downgrade Amid Market Concerns - GuruFocus
ResMed Shares Fall After Morgan Stanley Downgrade - Moomoo
Lobbying Update: $40,000 of RESMED CORP. lobbying was just disclosed - Quiver Quantitative
ResMed Inc. Stock 12‑Month Price Target Cut to $277.74, Implies 43% Upside - TradingView
This ResMed Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
ResMed stock downgraded at Morgan Stanley (RMD:NYSE) - Seeking Alpha
Resmed Completes Acquisition of Noctrix Health - San Diego Business Journal
Morgan Stanley Downgrades ResMed(RMD.US) to Hold Rating, Cuts Target Price to $230 - Moomoo
Morgan Stanley downgrades ResMed stock rating on margin concerns - Investing.com
Morgan Stanley Downgrades ResMed to Equalweight From Overweight, Adjusts PT to $230 From $286 - marketscreener.com
Morgan Stanley downgrades ResMed stock rating on margin concerns By Investing.com - Investing.com UK
Analyst recommendations: Block, Resmed, Applied Materials, Ge Vernova, Intel… - marketscreener.com
ResMed Inc. stock falls Monday, underperforms market - MarketWatch
ResMed Is Maintained at Buy by Citigroup - Moomoo
Do experts rate BHP, Cochlear, and ResMed shares as buys, holds, or sells? - MSN
Citigroup Adjusts Price Target on ResMed to $270 From $340, Maintains Buy Rating - marketscreener.com
2.91%
0.48%
大文字化:
|
ボリューム (24 時間):